Angiotensin converting enzyme 2, angiotensin-(1-7), and receptor mas axis in the kidney

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Pinheiro, Sergio Veloso Brant ^a   Simões E Silva, Ana Cristina ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR MAS; MATRIX PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; SODIUM; UNCLASSIFIED DRUG; WATER;

ALBUMINURIA; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; DIURESIS; ENZYME ACTIVITY; GENE EXPRESSION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY ISCHEMIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY MECHANISM; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SODIUM EXCRETION; TRANSGENIC ANIMAL; URETER OBSTRUCTION; URINARY EXCRETION; VASOCONSTRICTION; VASODILATATION;

EID: 84868277483     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/414128     Document Type: Review

References (83)

1. Schiavone M. T., Santos R. A. S., Brosnihan K. B., Khosla M. C., Ferrario C. M., Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(17) heptapeptide. Proceedings of the National Academy of Sciences of the United States of America 1988 85 11 4095 4098 2-s2.0-0000254274
2. Santos R. A. S., Ferreira A. J., Simões e Silva A. C., Recent advances in the angiotensin-converting enzyme 2-angiotensin(17)-Mas axis. Experimental Physiology 2008 93 5 519 527 2-s2.0-42649115768 10.1113/expphysiol.2008.042002 (Pubitemid 351595060)
3. Iwai M., Horiuchi M., Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(17)-Mas receptor axis. Hypertension Research 2009 32 7 533 536 2-s2.0-67650541842 10.1038/hr.2009.74
4. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 19. Circulation research 2000 87 5 E1 E9 2-s2.0-0038053724
5. Tipnis S. R., Hooper N. M., Hyde R., Karran E., Christie G., Turner A. J., A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 2000 275 43 33238 33243 2-s2.0-0034721906 10.1074/jbc.M002615200
6. Rice G. I., Thomas D. A., Grant P. J., Turner A. J., Hooper N. M., Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochemical Journal 2004 383, part 1 45 51 2-s2.0-6344246036 10.1042/BJ20040634 (Pubitemid 39389449)
7. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., Tummino P., Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry 2002 277 17 14838 14843 2-s2.0-18544378161 10.1074/jbc.M200581200 (Pubitemid 34952556)
8. Chappell M. C., Pirro N. T., Sykes A., Ferrario C. M., Metabolism of angiotensin-(17) by angiotensin-converting enzyme. Hypertension 1998 31 1, part 2 362 367 2-s2.0-0031600505
9. Stanziola L., Greene L. J., Santos R. A. S., Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. American Journal of Hypertension 1999 12 10, part 1 1021 1029 2-s2.0-0032732272 10.1016/S0895-7061(99)00090-4 (Pubitemid 29528702)
10. Campbell D. J., Zeitz C. J., Esler M. D., Horowitz J. D., Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. Journal of Hypertension 2004 22 10 1971 1976 2-s2.0-5044220674 10.1097/00004872-200410000-00020 (Pubitemid 39336680)
11. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H. P., Speth R., Walther T., Angiotensin-(17) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas.1432869100 (Pubitemid 36842532)
12. Santos R. A. S., Campagnole-Santos M. J., Baracho N. C. V., Fontes M. A. P., Silva L. C. S., Neves L. A. A., Oliveira D. R., Caligiorne S. M., Rodrigues A. R. V., Gropen C., Carvalho W. S., Silva A. C. S. E., Khosla M. C., Characterization of a new angiotensin antagonist selective for angiotensin-(17): evidence that the actions of angiotensin-(17) are mediated by specific angiotensin receptors. Brain Research Bulletin 1994 35 4 293 298 2-s2.0-0028061656 10.1016/0361-9230(94)90104-X (Pubitemid 24332669)
13. Ambühl P., Felix D., Khosla M. C., [7-D-Ala]-angiotensin-(17): selective antagonism of angiotensin-(17) in the rat paraventricular nucleus. Brain Research Bulletin 1994 35 4 289 291 2-s2.0-0028043668 10.1016/0361- 9230(94)90103-1 (Pubitemid 24332668)
14. Ferreira A. J., Santos R. A. S., Bradford C. N., Mecca A. P., Sumners C., Katovich M. J., Raizada M. K., Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 2010 55 2 207 213 2-s2.0-74949087578 10.1161/HYPERTENSIONAHA.109.140145
15. Chappell M. C., Gregory Modralt J., Diz D. I., Ferrario C. M., Novel aspects of the renal renin-angiotensin system: angiotensin-(17),ACE2 and blood pressure regulation. Contributions to Nephrology 2004 143 77 89 2-s2.0-3242695312
16. Allred A. J., Chappell M. C., Ferrario C. M., Diz D. I., Differential actions of renal ischemic injury on the intrarenal angiotensin system. American Journal of PhysiologyRenal Physiology 2000 279 4 F636 F645 2-s2.0-0033679815
17. Chappell M. C., Allred A. J., Ferrario C. M., Pathways of angiotensin-(17) metabolism in the kidney. Nephrology Dialysis Transplantation 2001 16 1 22 26 2-s2.0-0035007108
18. Ji H., Menini S., Zheng W., Pesce C., Wu X., Sandberg K., Role of angiotensin-converting enzyme 2 and angiotensin(17) in 17 β -oestradiol regulation of renal pathology in renal wrap hypertension in rats. Experimental Physiology 2008 93 5 648 657 2-s2.0-42649144447 10.1113/expphysiol.2007.041392 (Pubitemid 351595057)
19. Liu J., Ji H., Zheng W., Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17b-oestradioldependent and sex chromosome-independent. Biology of Sex Differences 2010 1 1 6
20. Ferrario C. M., Smith R. D., Brosnihan B., Chappell M. C., Campese V. M., Vesterqvist O., Liao W. C., Ruddy M. C., Grim C. E., Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. American Journal of Hypertension 2002 15 6 557 564 2-s2.0-0036015045 10.1016/S0895-7061(02)02268-9 (Pubitemid 34596964)
21. Ferrario C. M., Jessup J., Gallagher P. E., Averill D. B., Brosnihan K. B., Tallant E. A., Smith R. D., Chappell M. C., Effects of renin-angiotensin system blockade on renal angiotensin-(17) forming enzymes and receptors. Kidney International 2005 68 5 2189 2196 2-s2.0-30944453306 10.1111/j.1523-1755.2005. 00675.x (Pubitemid 43117793)
22. Simoes-e-Silva A. C., Baracho N. C. V., Passaglio K. T., Santos R. A. S., Renal actions of angiotensin-(17). Brazilian Journal of Medical and Biological Research 1997 30 4 503 513 2-s2.0-0031112423
23. Santos R. A. S., Passaglio K. T., Pesquero J. B., Bader M., Simões e Silva A. C., Interactions between angiotensin-(17), kinins, and angiotensin II in kidney and blood vessels. Hypertension 2001 38 3 660 664 2-s2.0-0035459470
24. Carey R. M., Siragy H. M., Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocrine Reviews 2003 24 3 261 271 2-s2.0-0037667643 (Pubitemid 36733542)
25. Ferrario C. M., Chappell M. C., Novel angiotensin peptides. Cellular and Molecular Life Sciences 2004 61 21 2720 2727 2-s2.0-11144297985 10.1007/s00018-004-4243-4 (Pubitemid 40022433)
26. Simões e Silva A. C., Pinheiro S. V. B., Pereira R. M., Ferreira A. J., Santos R. A. S., The therapeutic potential of Angiotensin-(17) as a novel Renin-Angiotensin System mediator. Mini-Reviews in Medicinal Chemistry 2006 6 5 603 609 2-s2.0-33646579401 10.2174/138955706776876203
27. Andreatta-Van Leyen S., Romero M. F., Khosla M. C., Douglas J. G., Modulation of phospholipase A2 activity and sodium transport by angiotensin-(17). Kidney International 1993 44 5 932 936 2-s2.0-0027330065 (Pubitemid 23316460)
28. Handa R. K., Angiotensin-(17) can interact with the rat proximal tubule AT4 receptor system. American Journal of PhysiologyRenal Physiology 1999 277 1, part 2 F75 F83 2-s2.0-0032811982 (Pubitemid 29352677)
29. +)ATPase activity by Angiotensin-(17) in MDCK cells. Regulatory Peptides 2005 129 13 221 226 2-s2.0-20144378491 10.1016/j.regpep.2005.02.014 (Pubitemid 40775806)
30. +-ATPase by Ang-(17). Biochemical Journal 2006 395 1 183 190 2-s2.0-33645567434 10.1042/BJ20051455
31. DelliPizzi A. M., Hilchey S. D., Bell-Quilley C. P., Natriuretic action of angiotensin(17). British Journal of Pharmacology 1994 111 1 1 3 2-s2.0-0028220786
32. Vallon V., Richter K., Heyne N., Osswald H., Effect of intratubular application of angiotensin 17 on nephron function. Kidney and Blood Pressure Research 1997 20 4 233 239 2-s2.0-0030662942 (Pubitemid 27487509)
33. López Ordieres M. G., Gironacci M., Rodríguez de Lores Arnaiz G., Peñ C., Effect of angiotensin-(17) on ATPase activities in several tissues. Regulatory Peptides 1998 77 13 135 139 2-s2.0-0032538288 10.1016/S0167-0115(98)00113-X (Pubitemid 28467099)
34. Bürgelová M., Kramer H. J., Teplan V., Velič ková G., Vítko Š.., Heller J., Mal J., Červenka L., Intrarenal infusion of angiotensin-(17) modulates renal functional responses to exogenous angiotensin II in the rat. Kidney and Blood Pressure Research 2002 25 4 202 210 2-s2.0-19044380248 10.1159/000066340 (Pubitemid 44858326)
35. Pinheiro S. V. B., Simões e Silva A. C., Sampaio W. O., de Paula R. D., Mendes E. P., Bontempo E. D., Pesquero J. B., Walther T., Alenina N., Bader M., Bleich M., Santos R. A. S., Nonpeptide AVE 0991 is an angiotensin-(17) receptor mas agonist in the mouse kidney. Hypertension 2004 44 4 490 496 2-s2.0-4644372221 10.1161/01.HYP.0000141438.64887.42 (Pubitemid 39281501)
36. Santos R. A. S., Baracho N. C. V., Angiotensin-(17) is a potent antidiuretic peptide in rats. Brazilian Journal of Medical and Biological Research 1992 25 6 651 654 2-s2.0-0026686144
37. Garcia N. H., Garvin J. L., Angiotensin 17 has a biphasic effect on fluid absorption in the proximal straight tubule. Journal of the American Society of Nephrology 1994 5 4 1133 1138 2-s2.0-0028525342 (Pubitemid 24977092)
38. Santos R. A. S., Simões e Silva A. C., Magaldi A. J., Khosla M. C., Cesar K. R., Passaglio K. T., Baracho N. C. V., Evidence for a physiological role of angiotensin-(17) in the control of hydroelectrolyte balance. Hypertension 1996 27 4 875 884 2-s2.0-9244221086 (Pubitemid 26113834)
39. Baracho N. C. V., Simões e Silva A. C., Khosla M. C., Santos R. A. S., Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(17) in water-loaded rats. Brazilian Journal of Medical and Biological Research 1998 31 9 1221 1227 2-s2.0-0031732218 (Pubitemid 28485113)
40. Simões e Silva A. C., Bello A. P. C., Baracho N. C. V., Khosla M. C., Santos R. A. S., Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(17) antagonist in normotensive and hypertensive rats. Regulatory Peptides 1998 74 2-3 177 184 2-s2.0-0344404304 10.1016/S0167-0115(98)00038-X (Pubitemid 28288980)
41. 2 receptors. Pflugers Archiv European Journal of Physiology 2003 447 2 223 230 2-s2.0-0842330491 10.1007/s00424-003-1173-1 (Pubitemid 38177737)
42. 7-angiotensin-(17). Hypertension 2003 41 3, part 2 737 743 2-s2.0-0037341829 10.1161/01.HYP. 0000052947.60363.24 (Pubitemid 36314584)
43. Ferreira A. J., Pinheiro S. V. B., Castro C. H., Silva G. A. B., Simões e Silva A. C., Almeida A. P., Bader M., Rentzsch B., Reudelhuber T. L., Santos R. A. S., Renal function in transgenic rats expressing an angiotensin-(17)-producing fusion protein. Regulatory Peptides 2006 137 3 128 133 2-s2.0-33751503376 10.1016/j.regpep.2006.06.005 (Pubitemid 44838976)
44. Navar L. G., Nishiyama A., Why are angiotensin concentrations so high in the kidney? Current Opinion in Nephrology and Hypertension 2004 13 1 107 115 2-s2.0-4043157826 10.1097/00041552-200401000-00015 (Pubitemid 39069906)
45. Brewster U. C., Perazella M. A., The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. American Journal of Medicine 2004 116 4 263 272 2-s2.0-1242351306 10.1016/j.amjmed.2003.09.034 (Pubitemid 38224234)
46. Jaimes E. A., Tian R. X., Pearse D., Raij L., Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney International 2005 68 5 2143 2153 2-s2.0-30944466085 10.1111/j.1523-1755.2005.00670.x (Pubitemid 43117788)
47. Ren Y., Garvin J. L., Carretero O. A., Vasodilator action of angiotensin-(17) on isolated rabbit afferent arterioles. Hypertension 2002 39 3 799 802 2-s2.0-0036194890 10.1161/hy0302.104673 (Pubitemid 34252879)
48. Sampaio W. O., Nascimento A. A. S., Santos R. A. S., Systemic and regional hemodynamic effects of angiotensin-(17) in rats. American Journal of PhysiologyHeart and Circulatory Physiology 2003 284 6 H1985 H1994 2-s2.0-0038024648 (Pubitemid 36622408)
49. Stegbauer J., Oberhauser V., Vonend O., Rump L. C., Angiotensin-(17) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovascular Research 2004 61 2 352 359 2-s2.0-0345861888 10.1016/j.cardiores.2003.11.017 (Pubitemid 38091775)
50. Santos R. A. S., Castro C. H., Gava E., Pinheiro S. V. B., Almeida A. P., De Paula R. D., Cruz J. S., Ramos A. S., Rosa K. T., Irigoyen M. C., Bader M., Alenina N., Kitten G. T., Ferreira A. J., Impairment of in vitro and in vivo heart function in angiotensin-(17) receptor mas knockout mice. Hypertension 2006 47 5 996 1002 2-s2.0-33646161714 10.1161/01.HYP.0000215289.51180.5c (Pubitemid 44297574)
51. Pereira R. M., Santos R. A. S., Teixeira M. M., Leite V. H. R., Costa L. P., da Costa Dias F. L., Barcelos L. S., Collares G. B., Simões e Silva A. C., The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(17). Journal of Hepatology 2007 46 4 674 681 2-s2.0-33947174603 10.1016/j.jhep.2006.10.018 (Pubitemid 46400144)
52. Pinheiro S. V. B., Ferreira A. J., Kitten G. T., Da Silveira K. D., Da Silva D. A., Santos S. H. S., Gava E., Castro C. H., Magalhes J. A., Da Mota R. K., Botelho-Santos G. A., Bader M., Alenina N., Santos R. A. S., Simoes E Silva A. C., Genetic deletion of the angiotensin-(17) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney International 2009 75 11 1184 1193 2-s2.0-67349127050 10.1038/ki.2009.61
53. Kuncio G. S., Neilson E. G., Haverty T., Mechanisms of tubulointerstitial fibrosis. Kidney International 1991 39 3 550 556 2-s2.0-0025865188
54. Harris R. C., Neilson E. G., Toward a unified theory of renal progression. Annual Review of Medicine 2006 57 365 380 2-s2.0-32944464939 10.1146/annurev.med.57.121304.131342 (Pubitemid 43261996)
55. Zhang J., Noble N. A., Border W. A., Huang Y., Infusion of angiotensin-(17) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. American Journal of PhysiologyRenal Physiology 2010 298 3 F579 F588 2-s2.0-77649125799 10.1152/ajprenal.00548.2009
56. Tallant E. A., Clark M. A., Molecular mechanisms of inhibition of vascular growth by angiotensin-(17). Hypertension 2003 42 4 574 579 2-s2.0-0141893551 10.1161/01.HYP.0000090322.55782.30 (Pubitemid 37237356)
57. Tallant E. A., Ferrario C. M., Gallagher P. E., Angiotensin-(17) inhibits growth of cardiac myocytes through activation of the mas receptor. American Journal of PhysiologyHeart and Circulatory Physiology 2005 289 4 H1560 H1566 2-s2.0-25444473110 10.1152/ajpheart.00941.2004 (Pubitemid 41368998)
58. Iwata M., Cowling R. T., Gurantz D., Moore C., Zhang S., Yuan J. X. J., Greenberg B. H., Angiotensin-(17) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. American Journal of PhysiologyHeart and Circulatory Physiology 2005 289 6 H2356 H2363 2-s2.0-28144432331 10.1152/ajpheart.00317.2005 (Pubitemid 41698543)
59. Gallagher P. E., Tallant E. A., Inhibition of human lung cancer cell growth by angiotensin-(17). Carcinogenesis 2004 25 11 2045 2052 2-s2.0-8844265279 10.1093/carcin/bgh236 (Pubitemid 39534840)
60. Su Z., Zimpelmann J., Burns K. D., Angiotensin-(17) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney International 2006 69 12 2212 2218 2-s2.0-33745066911 10.1038/sj.ki.5001509 (Pubitemid 43882108)
61. Oudit G. Y., Herzenberg A. M., Kassiri Z., Wong D., Reich H., Khokha R., Crackower M. A., Backx P. H., Penninger J. M., Scholey J. W., Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. American Journal of Pathology 2006 168 6 1808 1820 2-s2.0-33744731510 10.2353/ajpath.2006.051091 (Pubitemid 43825302)
62. Wysocki J., Ye M., Soler M. J., Gurley S. B., Xiao H. D., Bernstein K. E., Coffman T. M., Chen S., Batlle D., ACE and ACE2 activity in diabetic mice. Diabetes 2006 55 7 2132 2139 2-s2.0-33747052918 10.2337/db06-0033 (Pubitemid 44509989)
63. Ye M., Wysocki J., William J., Soler M. J., Cokic I., Batlle D., Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. Journal of the American Society of Nephrology 2006 17 11 3067 3075 2-s2.0-33750722109 10.1681/ASN.2006050423 (Pubitemid 44707767)
64. Wong D. W., Oudit G. Y., Reich H., Kassiri Z., Zhou J., Liu Q. C., Backx P. H., Penninger J. M., Herzenberg A. M., Scholey J. W., Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. American Journal of Pathology 2007 171 2 438 451 2-s2.0-34548295365 10.2353/ajpath.2007.060977 (Pubitemid 47344677)
65. Soler M. J., Wysocki J., Ye M., Lloveras J., Kanwar Y., Batlle D., ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney International 2007 72 5 614 623 2-s2.0-34548153521 10.1038/sj.ki.5002373 (Pubitemid 47312795)
66. Dilauro M., Zimpelmann J., Robertson S. J., Genest D., Burns K. D., Effect of ACE2 and angiotensin-(17) in a mouse model of early chronic kidney disease. American Journal of PhysiologyRenal Physiology 2010 298 6 F1523 F1532 2-s2.0-77952737389 10.1152/ajprenal.00426.2009
67. Silveira K. D., Pompermayer Bosco K. S., Diniz L. R. L., Carmona A. K., Cassali G. D., Bruna-Romero O., De Sousa L. P., Teixeira M. M., Santos R. A. S., Simões E Silva A. C., Ribeiro Vieira M. A., ACE2-angiotensin-(17)-Mas axis in renal ischaemia/reperfusion injury in rats. Clinical Science 2010 119 9 385 394 2-s2.0-77956370495 10.1042/CS20090554
68. Ferrario C. M., ACE2: more of Ang-(17) or less Ang II? Current Opinion in Nephrology and Hypertension 2011 20 1 1 6 2-s2.0-77958596701 10.1097/MNH.0b013e3283406f57
69. Santos R. A. S., Ferreira A. J., Simões e Silva A. C., Bader M., Angiotensins. Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics 2008 1 Weinheim, Germany Wiley-VCH 67 100
70. Simões E Silva A. C., Flynn J. T., The renin-angiotensin- aldosterone system in 2011: role in hypertension and chronic kidney disease. Pediatric Nephrology. In press 10.1007/s00467-011-2002-y
71. Esteban V., Heringer-Walther S., Sterner-Kock A., de Bruin R., van den Engel S., Wang Y., Mezzano S., Egido J., Schultheiss H. P., Ruiz-Ortega M., Walther T., Angiotensin-(17) and the G protein-coupled receptor Mas are key players in renal inflammation. PLoS ONE 2009 4 4 2-s2.0-65549108738 10.1371/journal.pone.0005406 e5406
72. Velkoska E., Dean R. G., Griggs K., Burchill L., Burrell L. M., l.burrell@unimelb.edu.au Angiotensin-(17) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clinical Science 2011 120 8 335 345 10.1042/CS20100280
73. Zimpelmann J., Burns K. D., Angiotensin-(17) activates growth-stimulatory pathways in human mesangial cells. American Journal of PhysiologyRenal Physiology 2009 296 2 F337 F346 2-s2.0-60549095158 10.1152/ajprenal.90437.2008
74. van der Wouden E. A., Ochodnick P., Van Dokkum R. P., Roks A. J., Deelman L. E., De Zeeuw D., Henning R. H., The role of angiotensin(17) in renal vasculature of the rat. Journal of Hypertension 2006 24 10 1971 1978 2-s2.0-33748571141 10.1097/01.hjh.0000244945.42169.c0 (Pubitemid 44371263)
75. Mizuiri S., Hemmi H., Arita M., Aoki T., Ohashi Y., Miyagi M., Sakai K., Shibuya K., Hase H., Aikawa A., Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy. NephronClinical Practice 2010 117 1 c57 c66 2-s2.0-77955098970 10.1159/000319648
76. Simões e Silva A. C., Diniz J. S. S., Pereira R. M., Pinheiro S. V. B., Santos R. A. S., Circulating renin angiotensin system in childhood chronic renal failure: marked increase of angiotensin-(17) in end-stage renal disease. Pediatric Research 2006 60 6 734 739 2-s2.0-33751254359 10.1203/01.pdr. 0000246100.14061.bc (Pubitemid 44789518)
77. Luque M., Martin P., Martell N., Fernandez C., Brosnihan K. B., Ferrario C. M., Effects of captopril related to increased levels of prostacyclin and angiotensin-(17) in essential hypertension. Journal of Hypertension 1996 14 6 799 805 2-s2.0-0029974215 10.1097/00004872-199606000-00017 (Pubitemid 26187416)
78. Azizi M., Ménard J., Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 2004 109 21 2492 2499 2-s2.0-2642575030 10.1161/01.CIR.0000131449.94713.AD (Pubitemid 38720545)
79. Kocks M. J. A., Lely A. T., Boomsma F., de Jong P. E., Navis G., Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(17) in healthy man. Journal of Hypertension 2005 23 3 597 602 2-s2.0-18844390994 (Pubitemid 40691197)
80. Taal M. W., Brenner B. M., Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney International 2000 57 5 1803 1817 2-s2.0-0034118392 10.1046/j.1523-1755.2000.00031.x (Pubitemid 30252273)
81. Codreanu I., Perico N., Remuzzi G., Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? Journal of the American Society of Nephrology 2005 16 3 S34 S38 2-s2.0-20844454491 10.1681/ASN.2004110966 (Pubitemid 41725080)
82. Ferrario C. M., Martell N., Yunis C., Flack J. M., Chappell M. C., Brosnihan K. B., Dean R. H., Fernandez A., Novikov S. V., Pinillas C., Luque M., Characterization of angeotensin-(17) in the urine of normal and essential hypertensive subjects. American Journal of Hypertension 1998 11 2 137 146 2-s2.0-0031594360 10.1016/S0895-7061(97)00400-7 (Pubitemid 28137604)
83. Simões e Silva A. C., Diniz J. S. S., Regueira Filho A., Santos R. A. S., The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(17) in essential hypertension. Journal of Pediatrics 2004 145 1 93 98 2-s2.0-3242707890 10.1016/j.jpeds.2004.03.055 (Pubitemid 38962458)